The Australian Government will invest more than $5.4 million in three groundbreaking brain cancer research projects.&nbs...
Australians with inherited retinal disease (IRD) have a strong interest in undergoing gene therapy to prevent and treat ...
Australians will soon be able to count on better care and treatment for attention deficit hyperactivity disorder (ADHD) ...
Global molecular diagnostics innovator Sense Biodetection has entered into a strategic agreement with Aba...
US-based Pfizer has acquired University of Queensland (UQ) startup ResApp Health Limited for $179 million. Res...
In a discovery that may help scientists alleviate the global burden of grass pollen allergans, Monash researchers i...
The Australian Government’s Medical Research Future Fund (MRFF) has invested $28 million in funding for Monash res...
The University of Sydney and The Centenary Institute, together with collaborators have been awarded an AU$19 million con...
The way Australian women are screened for breast cancer could be fundamentally changed, owing to a new National Health a...
Australian scientists will use new technology to improve the diagnosis and treatment of blood cancers, which affect 1.24...
Cynata Therapeutics has announced that the Australian Government National Health and Medical Research Council (NHMRC) ha...
Australia’s leading provider of toxicology and bioanalytical contract services, Agilex Biolabs has expanded its ca...
The Australian government is investing in a new study on COVID-19 vaccines and infection to ultimately improve the care ...
A $400,000 robot which could significantly improve hip and knee replacements is now operational at the Kolling Institute...
Australia's Medibio Limited has announced the appointment of Dr Thomas R. Young, M.D. as the company’s Chief Execu...
Australia's PolyNovo has received US FDA 510(k) clearance for NovoSorb MTX, a major new product innovation for sof...
Researchers at the Australian National Phenome Centre (ANPC) at Murdoch University have successfully detected and quanti...
Australian firm EpiAxis Therapeutics, a leading epigenetics company with a focus on cancer treatment and prevention recu...
